文献速递糖尿病肥胖与代谢综合征

他汀类药物治疗与2型糖尿病之间的表观遗传学联系

Epigenetic Link Between Statin Therapy and Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2020-02-07

在5项队列研究共8270名参与者中,比较他汀使用者与非使用者的DNA甲基化,发现5个甲基化位点与他汀使用相关,其中cg06500161甲基化升高与空腹血糖、胰岛素、HOMA-IR及2型糖尿病风险升高相关(OR 1.34)。ABCG1甲基化可能部分介导他汀对高胰岛素和HOMA-IR的影响。

要点

  • 他汀使用与5个DNA甲基化位点相关,包括DHCR24、ABCG1和SC4MOL基因区域。
  • cg06500161甲基化升高与空腹血糖、胰岛素、HOMA-IR及2型糖尿病风险升高相关(OR 1.34)。
  • ABCG1甲基化可能部分介导他汀对高胰岛素和HOMA-IR的影响。

核心结论

  • 本研究揭示了他汀与2型糖尿病风险之间的潜在机制,提供DNA甲基化部分介导他汀对胰岛素特征影响的证据。
  • 需要进一步努力阐明他汀可能诱导DNA甲基化改变的分子机制,这可能导致ABCG1的表观遗传调控。

研究设计与样本

  • 表观全基因组关联研究,纳入5项队列研究的参与者共8270人。
  • 他汀使用者定义为在DNA甲基化评估时正在接受他汀治疗,使用Illumina 450K或EPIC芯片。
  • 非当前使用者定义为其他情况。
  • 发现阶段6820人,复制阶段1450人。

主要发现

  • 发现和复制阶段关联5个DNA甲基化位点与他汀使用:cg17901584(1.12×10^-25,DHCR24)、cg10177197(3.94×10^-08,DHCR24)、cg06500161(2.67×10^-23,ABCG1)、cg27243685(6.01×10^-09,ABCG1)、cg05119988(7.26×10^-12,SC4MOL)。
  • cg06500161甲基化升高与较高的空腹血糖、胰岛素、HOMA-IR及2型糖尿病相关(比值比1.34[95%CI 1.22, 1.47])。
  • 中介分析提示ABCG1甲基化部分介导他汀对高胰岛素和HOMA-IR的影响。
  • 基因表达分析显示他汀暴露和ABCG1甲基化与ABCG1下调相关,提示ABCG1表达的表观遗传调控。
  • 胰岛素和HOMA-IR与ABCG1表达显著相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the role of epigenetics in statins' diabetogenic effect comparing DNA methylation (DNAm) between statin users and nonusers in an epigenome-wide association study in blood. RESEARCH DESIGN AND METHODS: Five cohort studies' participants (n = 8,270) were classified as statin users when they were on statin therapy at the time of DNAm assessment with Illumina 450K or EPIC array or noncurrent users otherwise. Associations of DNAm with various outcomes like incident type 2 diabetes, plasma glucose, insulin, and insulin resistance (HOMA of insulin resistance [HOMA-IR]) as well as with gene expression were investigated. RESULTS: Discovery (n = 6,820) and replication (n = 1,450) phases associated five DNAm sites with statin use: cg17901584 (1.12 × 10-25 [DHCR24]), cg10177197 (3.94 × 10-08 [DHCR24]), cg06500161 (2.67 × 10-23 [ABCG1]), cg27243685 (6.01 × 10-09 [ABCG1]), and cg05119988 (7.26 × 10-12 [SC4MOL]). Two sites were associated with at least one glycemic trait or type 2 diabetes. Higher cg06500161 methylation was associated with higher fasting glucose, insulin, HOMA-IR, and type 2 diabetes (odds ratio 1.34 [95% CI 1.22, 1.47]). Mediation analyses suggested that ABCG1 methylation partially mediates the effect of statins on high insulin and HOMA-IR. Gene expression analyses showed that statin exposure and ABCG1 methylation were associated with ABCG1 downregulation, suggesting epigenetic regulation of ABCG1 expression. Further, outcomes insulin and HOMA-IR were significantly associated with ABCG1 expression. CONCLUSIONS: This study sheds light on potential mechanisms linking statins with type 2 diabetes risk, providing evidence on DNAm partially mediating statins' effects on insulin traits. Further efforts shall disentangle the molecular mechanisms through which statins may induce DNAm changes, potentially leading to ABCG1 epigenetic regulation.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ochoa-Rosales C, Portilla-Fernandez E, Nano J, et al. Epigenetic Link Between Statin Therapy and Type 2 Diabetes. Diabetes Care. 2020. PMID: 32033992. doi:10.2337/dc19-1828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。